Pharmaceutical giant Bristol-Myers Squibb (BMS) sued the federal government late Tuesday to establish a 340B rebate model, joining at least [...] …
Category: Providers
Drugmaker contact pharmacy restrictions that apply to all covered entities have now outpaced those that only apply to hospitals, according [...] …
Provider groups have strongly denounced Sanofi’s new 340B rebate model for hospitals and health centers as a costly and harmful [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Three large hospital systems are asking a federal court to immediately block the government from removing them from the 340B [...] …
Breaking News
Wall Street Journal Reports Sanofi Will Become Third Drugmaker to Push for Controversial 340B Rebate
French pharmaceutical giant Sanofi reportedly plans to announce a 340B rebate model for hospitals today, making it the third drugmaker [...] …
News Alert
Proposition 34: Voters Narrowly Back Controversial California 340B ‘Revenge’ Ballot Measure
California voters have narrowly endorsed Proposition 34, a controversial Nov. 5 ballot measure that would require at least one major [...] …
Katheryne Richardson, a former senior global pricing strategist at Bristol-Myers Squibb (BMS) and longtime vice president of Apexus, this week [...] …
The 340B program is increasing healthcare costs for employers and driving hospital consolidation, argued panelists at a recent healthcare purchaser [...] …
Breaking News
Lilly Sues HHS, HRSA to Implement Expansive 340B Rebate for All Products and Covered Entity Types
Eli Lilly on Thursday sued the federal government to implement a sweeping 340B rebate model that would apply to all [...] …